Crisis-Ready: Building a Resilient Supply
How can European pharma better prepare for future emergencies?
Maryam Mahdi | | Quick Read
Drawing on lessons learned from the COVID-19 pandemic, the European Commission has developed a plan to secure affordable medicines for patients across the region (1). Pharmaceutical Strategy for Europe aims to create a regulatory approach that offers guidance on the management of future crises and supply chain resilience. The strategy also outlines the Commission’s goals for creating a competitive industry with a “strong voice” on issues affecting the global pharmaceutical community.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine